• Citer

BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism.

par Vaerman, J L;Lammineur, C;Moureau, P.;Lewalle, Philippe ;Deldime, F;Blumenfeld, M;Martiat, Philippe
Référence Blood, 86, 10, page (3891-3896)
Publication Publié, 1995-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism.
Auteur:	Vaerman, J L; Lammineur, C; Moureau, P.; Lewalle, Philippe; Deldime, F; Blumenfeld, M; Martiat, Philippe
Informations sur la publication:	Blood, 86, 10, page (3891-3896)
Statut de publication:	Publié, 1995-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Base Sequence
	Cell Division -- drug effects
	Consensus Sequence
	Fusion Proteins, bcr-abl -- genetics
	Growth Inhibitors -- pharmacology
	Hematopoietic Stem Cells -- drug effects
	Humans
	Leukemia -- pathology
	Molecular Sequence Data
	Neoplastic Stem Cells -- drug effects
	Oligonucleotides, Antisense -- pharmacokinetics
	Oligonucleotides, Antisense -- pharmacology
	Tumor Cells, Cultured -- drug effects
	Tumor Stem Cell Assay
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0006-4971
	info:pmid/7579358